Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/30/2003WO2002068594A3 Opiate receptors
05/30/2003WO2002065137A3 Diagnosis of atherosclerosis
05/30/2003WO2002065135A3 Determination of level of immunoglobulin modification
05/30/2003WO2002064790A3 Jfy1 protein induces rapid apoptosis
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003WO2002061387A3 Open substrate platforms suitable for analysis of biomolecules
05/30/2003WO2002061114A3 Water-soluble, fluorescent and mobile peptide substrates
05/30/2003WO2002057416B1 Improved biochip
05/30/2003WO2002057314A3 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
05/30/2003WO2002053728A9 Gene disruption methodologies for drug target discovery
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002050309A3 A bardet-biedl susceptibility gene and uses thereof
05/30/2003WO2002041839A3 Assays for inhibitors of neuronal transport of alzheimer's amyloid precursor protein
05/30/2003WO2002040710A3 Method for detecting methylation states for a toxicological diagnostic
05/30/2003WO2002039086A8 Glucose sensor system
05/30/2003WO2002038608A9 Methods of screening for ltrpc2 modulators
05/30/2003WO2002036148A3 Use of death receptor ligands or rip to initiate the non-caspase-dependent cell death and compounds for inhibition of the non-caspase-dependent cell death
05/30/2003WO2002031025A9 Biodegradable poly(beta-amino esters) and uses thereof
05/30/2003WO2002014862A3 Method and device for characterising and/or for detecting a bonding complex
05/30/2003WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001004633A3 Preparation of spheres for diagnostic tests
05/30/2003CA2644157A1 Electrodes, methods, apparatuses comprising micro-electrode arrays
05/30/2003CA2492536A1 Postsynaptic proteins
05/30/2003CA2468526A1 Fluid analyser systems
05/30/2003CA2468170A1 Method for identification of tumor targeting enzymes
05/30/2003CA2468107A1 Methods for identifying and validating potential drug targets
05/30/2003CA2468041A1 Optical bio-discs and microfluidic devices for analysis of cells
05/30/2003CA2467908A1 Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages
05/30/2003CA2467756A1 Alpha-fetoprotein peptides and uses thereof
05/30/2003CA2467740A1 Methods and apparatus for blood typing with optical bio-discs
05/30/2003CA2467563A1 Cell and tissue arrays and microarrays and methods of use
05/30/2003CA2467456A1 Method of using a non-antibody protein to detect and measure an analyte
05/30/2003CA2467455A1 Method of detection of prostate cancer
05/30/2003CA2467248A1 Automated sample preparation methods and devices
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467050A1 Method for detecting analyte(s) using magnetic colloidal particles
05/30/2003CA2467020A1 Tumor specific monoclonal antibodies
05/30/2003CA2466578A1 Methods and devices for the integrated discovery of cell culture environments
05/30/2003CA2464957A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003CA2464542A1 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003CA2464350A1 Microfluidic system for proteome analysis
05/30/2003CA2463862A1 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003CA2462819A1 Method and kit for proximity probing with multivalent proximity probes
05/30/2003CA2458615A1 Flow-controlled magnetic particle manipulation
05/30/2003CA2451561A1 Size-exclusion filtering device, method for making same and resulting filtering method
05/30/2003CA2413177A1 Methods for detecting cells with numerical chromosomal abnormalities
05/29/2003US20030101012 Biometric quality control process
05/29/2003US20030101004 Lipoprotein assay
05/29/2003US20030101001 Identifying sequence motifs characteristic of G-protein-coupled receptor subfamilies and using these motifs to classify "orphan GPCRs"
05/29/2003US20030101000 Family based tests of association using pooled DNA and SNP markers
05/29/2003US20030100999 System and method for managing gene expression data
05/29/2003US20030100998 Systems and methods for monitoring behavior informatics
05/29/2003US20030100997 Matrix assays in genomically indexed cells
05/29/2003US20030100842 Method and kit for indicating the level of bad breath
05/29/2003US20030100707 Chimeric protein for use in the treatment of viral and nervous system disorders
05/29/2003US20030100632 Method and apparatus for predicting polymer latex properties in an emulsion polymerization process to improve the quality and productivity of the polymer latex
05/29/2003US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors
05/29/2003US20030100540 Identification of NSAID-regulated genes
05/29/2003US20030100538 Substituted chalcones as therapeutic compounds
05/29/2003US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100499 Incubating cells in a well containing culture medium; determining number of cells that migrate into lower chamber after incubation; comparing rate of proliferation of those cells that migrate and those cells that do not migrate
05/29/2003US20030100489 For determining if a subject is at risk for a disorder characterized by unwanted cell proliferation
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100486 Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
05/29/2003US20030100485 Human neurotrimin homolog
05/29/2003US20030100484 Cell in which a urotensin II receptor is formed is contacted with a chemical compound; activity or quantity of a gene, or its gene product, from the cell from is determined, comparing with gene product of control cell
05/29/2003US20030100482 NMDA oxidizing agents for protecting neurons from injury
05/29/2003US20030100475 Identifying taxonomical classification and probable biological function of endogenous target macromolecule of a test drug substance by comparing the membrane surface affinities of test drug substance with compounds having a known classification
05/29/2003US20030100130 Crystal compound for use as tool in medical and nonmedical fluorescence microscopy, histology, flow cytometry, in situ hybridization, immunoassays and nucleotide sequences separation and determination
05/29/2003US20030100129 Multi-partite ligands and methods of identifying and using same
05/29/2003US20030100128 Determination of concentation of preferential particles in sample using signal associated with binding activity; obtain sample, incubate with binding agent, detect signal, compare to control, determine concentration of particle
05/29/2003US20030100127 Immobilizing biomolecules or cells to metal substrate; provide metal surface, deposit monolayer on surface, incubate with protected biopolymer, deprotect and attach to metal surface
05/29/2003US20030100126 Antibody for use in the diagnosis of diabetic disorders
05/29/2003US20030100125 Filtering particles from liquid sample; obtain fluid sample, deposit on filter, determine time it took for fluid to pass through filter, compare to control
05/29/2003US20030100122 Detection of bacterial infection in mammals; obtain body fluid or tissue, determine concentration of 3-chlorotyrosine or 3-bromotyrosine in tissue, compare to control, amplified concentrations indicate infections
05/29/2003US20030100118 Polymeric food spoilage sensor
05/29/2003US20030100117 Standards, methods for making, and methods for using the standards in evaluation of oxide removal
05/29/2003US20030100103 Apparatus for use in the detection of preferential antigensor antibodies sample
05/29/2003US20030100102 Apparatus and method for sequencing a nucleic acid
05/29/2003US20030100091 Metalloprotease-disintegrin ADAM23 (SVPH3-17)
05/29/2003US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders
05/29/2003US20030100068 RANKL mimics and uses thereof
05/29/2003US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100060 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against venzuelan equine encephalitis virus (VEE)
05/29/2003US20030100059 Novel cell-based assays for G-protein-coupled receptor-mediated activities
05/29/2003US20030100039 Novel human phospholipase c delta 5
05/29/2003US20030100038 Diagnostic assay for stroke
05/29/2003US20030100036 Saliva immunoassay for detection of antibodies for cardiovascular disease
05/29/2003US20030100035 Diagnosing autoimmune disease in humans; obtain fluid sample, monitor concentration of marker antibodies, compare to control, evaluate for autoimmune diseases
05/29/2003US20030100034 Detection of modulators of cell activity; obtain cell, incubate with modulator, measure the concentration of target polypeptide, evaluate for cancer
05/29/2003US20030100033 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer in mammals
05/29/2003US20030100032 Methods and materials for the diagnosis and treatment of sporadic basal cell carcinoma
05/29/2003US20030100031 Integrative assays for monitoring molecular assembly events
05/29/2003US20030100030 Biosensor for use as diagnostic tool in medicine
05/29/2003US20030100029 Methods of determining active levels of drugs in fluid samples
05/29/2003US20030100028 Monitoring lipid activity in sample; obtain sample containing protein with lipid recognition domain, incubate with lipid and competitor, monitor and evaluate binding activity
1 ... 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 ... 3937